Role of Serum Vascular Endothelial Growth Factor (VEGF) as a Potential Biomarker of Response to Immune Checkpoint Inhibitor Therapy in Advanced Melanoma: Results of a Pilot Study

類似資料

• PD‐L1 Expression on Circulating Tumor Cells May Be Predictive of Response to Pembrolizumab in Advanced Melanoma: Results from a Pilot Study
  著者:: Khattak, Muhammad A., 等
  出版事項: (2019)
• Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies
  著者:: McEvoy, Ashleigh C., 等
  出版事項: (2019)
• Advances in Personalized Targeted Treatment of Metastatic Melanoma and Non-Invasive Tumor Monitoring
  著者:: Klinac, Dragana, 等
  出版事項: (2013)
• Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
  著者:: McEvoy, Ashleigh C., 等
  出版事項: (2018)
• Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells
  著者:: Aya-Bonilla, Carlos Alberto, 等
  出版事項: (2020)